MGRX (Mangoceuticals) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


MGRX Mangoceuticals Inc MGRX
26 GF Score
Price $0.37
GF Value $0.31
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Mangoceuticals Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Mangoceuticals's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

MGRX vs WLSS, BRGX, ACON: Margin of Safety % (DCF FCF Based) Comparison

For the Health Information Services subindustry, Mangoceuticals's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangoceuticals Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mangoceuticals's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Mangoceuticals's Margin of Safety % (DCF FCF Based) falls into.


MGRX
26GF Score
Mangoceuticals Inc MGRX
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mangoceuticals (MGRX) Overvalued in 2026?

Based on GuruFocus' analysis, Mangoceuticals stock appears to be overvalued. The current stock price of $0.37 is trading 19.3% above its estimated GF Value™ of $0.31. GuruFocus considers Mangoceuticals to be Modestly Overvalued.

Key valuation signals for MGRX:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $0.31 vs. price of $0.37 (19.3% above fair value)
  • GF Score™: 26/100 with 2 warning signs

No single metric tells the full story. See the MGRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mangoceuticals Business Description

Address 17130 Dallas Parkway, Suite 240, Dallas, TX, USA, 75248
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
26GF Score

Get the complete analysis for MGRX

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.31
GF Value